Research Studies
Correlation of Presumptive Positive using TMS with Next generation sequencing (NGS) for Inborn Errors of Metabolism: a pilot clinical study for Indian newborn population.
Inborn errors of metabolism are rare inherited disorders which leads to significant morbidity and mortality in patients. Very few studies have been conducted in India to assess prevalence of Inborn Er...
Determination of the clinical relevance of NIPS for the detection of fetal aneuploidies using NGS and understanding factors affecting the fetal fraction
Prenatal screening with maternal biochemical dual and quadruple markers, along with reflex testing using karyotyping, and non-invasive prenatal testing via next-generation sequencing (NIPT-NGS) were e...
Comparative analysis of thinprep and cell solution liquid based cervical cytology with hpv testing: a study of 412 cases
Cervical cancer remains a major health burden, particularly in developing countries, where inadequate screening contributes substantially to mortality. LBC improves smear quality and allows the residu...
Analysis of mutation spectrum in hboc cohort specifically brca 1/2 of Indian population
The objective of this study was to determine the prevalence and spectrum of genetic mutations linked to inherited breast and ovary cancer (HBOC) in the Indian population, and to evaluate the cor...
Analysis, morphological characterization, immunohistochemistry and fluorescence in-situ hybridization of Adult and Paediatric Indian Soft Tissue Sarcoma population
This study evaluated the spectrum and diagnostic characteristics of malignant soft tissue sarcomas in the Indian population through a retrospective analysis of 25,109 soft tissue cases, including 1,21...
About Us
Metropolis Healthcare is one of India’s leading diagnostics companies, with 45 years of experience built on scientific expertise, quality and trust. We serve millions of patients through a growing network supported by advanced laboratory infrastructure, technology and a patient-first approach. Our comprehensive portfolio includes 4,500+ tests and profiles across routine, specialised and super-specialised diagnostics, spanning pathology, molecular diagnostics, genomics, cytogenetics, oncology, neurology, nephrology, women and child health, preventive healthcare and wellness.
With 210+ clinical laboratories and a service network of 5,000+ touchpoints reaching more than 750 towns in India, we are focused on making trusted diagnostic services more accessible while maintaining rigorous quality standards. By combining scientific excellence, advanced technology and human expertise, we deliver accurate, reliable and relevant diagnostic insights that support better-informed healthcare decisions.